Surrozen, Inc.
SRZNBiotechnology
$29.46−2.93%As of Oct 29vs prior close
- Market cap
- $515.4M
- P/E (TTM)
- –
- From 52W high
- −13.68%
- EPS (LTM)
- -$39.55
- Revenue (LTM)
- $11.5M
- Net margin
- -2885.33%
- Dividend yield
- 0.00%
Nomior Score
36
Emerging BreakoutSpeculativeBottom 24% of the scored universe
Growth41
Quality21
Value32
Momentum91
Resilience30
Growth
$11.5Mrevenue, LTM
YE21 $0LTM $11.5M
Connections
Revenue to profitQ2 YE26
The operating loss was 207% of revenue, narrower by 710 pts on a year.
Who owns it
2funds